Sodium-glucose cotransporter-2 (SGLT2) inhibitors can slow diabetic kidney disease, but less is known about their…
karnottAugust 10, 2026
Advancements in cancer treatment over the last half century mean that more than 85% of…
karnottAugust 7, 2026
Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here we…
karnottAugust 6, 2026
Schizophrenia affects approximately 23 million people worldwide, with onset usually occurring during a person’s late…
karnottAugust 6, 2026
Cole DeForest — MolES director of education and Weyerhaeuser endowed professor of Chemical Engineering and…
karnottAugust 6, 2026
Drug development is among the slowest, most failure-prone processes in modern science, with about 90%…
karnottAugust 5, 2026
Two recent events underscore the Brotman Baty Institute’s commitment to educating the next generation of…
karnottAugust 5, 2026
A $1.5 million award from the Gates Foundation will support the next phase of Nextstrain,…
karnottAugust 4, 2026
